BBOT
BridgeBio Oncology Therapeutics, Inc. Common Stock
BBOT
BBOT
34 hedge funds and large institutions have $178M invested in BridgeBio Oncology Therapeutics, Inc. Common Stock in 2025 Q2 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 4 closing their positions.
Holders
34
Holders Change
+3
Holders Change %
+9.68%
% of All Funds
0.46%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.01%
New
7
Increased
7
Reduced
4
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–